Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

NASDAQ:MANH - Nasdaq - US5627501092 - Common Stock - Currency: USD

163.57  +2.48 (+1.54%)

After market: 163.57 0 (0%)

Fundamental Rating

7

Taking everything into account, MANH scores 7 out of 10 in our fundamental rating. MANH was compared to 283 industry peers in the Software industry. MANH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MANH is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make MANH a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
In the past year MANH had a positive cash flow from operations.
MANH had positive earnings in each of the past 5 years.
Each year in the past 5 years MANH had a positive operating cash flow.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

With an excellent Return On Assets value of 28.82%, MANH belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
MANH has a better Return On Equity (73.00%) than 97.17% of its industry peers.
With an excellent Return On Invested Capital value of 60.22%, MANH belongs to the best of the industry, outperforming 99.65% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MANH is significantly above the industry average of 11.25%.
The 3 year average ROIC (55.23%) for MANH is below the current ROIC(60.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 28.82%
ROE 73%
ROIC 60.22%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of MANH (20.95%) is better than 85.87% of its industry peers.
MANH's Profit Margin has improved in the last couple of years.
The Operating Margin of MANH (25.10%) is better than 91.17% of its industry peers.
MANH's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 54.82%, MANH is not doing good in the industry: 65.37% of the companies in the same industry are doing better.
MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.1%
PM (TTM) 20.95%
GM 54.82%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MANH is creating value.
MANH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MANH has less shares outstanding
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MANH has an Altman-Z score of 16.28. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MANH (16.28) is better than 92.93% of its industry peers.
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.28
ROIC/WACC5.52
WACC10.9%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.26 indicates that MANH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, MANH is not doing good in the industry: 61.84% of the companies in the same industry are doing better.
A Quick Ratio of 1.26 indicates that MANH should not have too much problems paying its short term obligations.
MANH's Quick ratio of 1.26 is on the low side compared to the rest of the industry. MANH is outperformed by 61.48% of its industry peers.
MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

MANH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.80%, which is quite impressive.
MANH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.14% yearly.
The Revenue has grown by 12.24% in the past year. This is quite good.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)25.8%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%13.59%
Revenue 1Y (TTM)12.24%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%7.36%

3.2 Future

Based on estimates for the next years, MANH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.55% on average per year.
The Revenue is expected to grow by 8.65% on average over the next years. This is quite good.
EPS Next Y-1.49%
EPS Next 2Y4.87%
EPS Next 3Y8.81%
EPS Next 5Y17.55%
Revenue Next Year1.98%
Revenue Next 2Y4.97%
Revenue Next 3Y7.23%
Revenue Next 5Y8.65%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.58 indicates a quite expensive valuation of MANH.
62.54% of the companies in the same industry are more expensive than MANH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MANH to the average of the S&P500 Index (28.29), we can say MANH is valued slightly more expensively.
With a Price/Forward Earnings ratio of 35.10, MANH can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MANH is valued a bit cheaper than 62.54% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.08, MANH is valued quite expensively.
Industry RankSector Rank
PE 34.58
Fwd PE 35.1
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

69.61% of the companies in the same industry are more expensive than MANH, based on the Enterprise Value to EBITDA ratio.
67.84% of the companies in the same industry are more expensive than MANH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.68
EV/EBITDA 36.07
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of MANH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.56
EPS Next 2Y4.87%
EPS Next 3Y8.81%

0

5. Dividend

5.1 Amount

MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (4/17/2025, 8:00:00 PM)

After market: 163.57 0 (0%)

163.57

+2.48 (+1.54%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-28 2025-01-28/amc
Earnings (Next)04-22 2025-04-22/amc
Inst Owners101.69%
Inst Owner Change0%
Ins Owners1.18%
Ins Owner Change7.26%
Market Cap9.93B
Analysts82.35
Price Target250.58 (53.19%)
Short Float %2.3%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.32%
Min EPS beat(2)8.28%
Max EPS beat(2)24.36%
EPS beat(4)4
Avg EPS beat(4)17.44%
Min EPS beat(4)8.28%
Max EPS beat(4)24.36%
EPS beat(8)8
Avg EPS beat(8)21.53%
EPS beat(12)12
Avg EPS beat(12)25.21%
EPS beat(16)16
Avg EPS beat(16)26.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.78%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)-0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)2.53%
Revenue beat(8)6
Avg Revenue beat(8)2.85%
Revenue beat(12)10
Avg Revenue beat(12)3.5%
Revenue beat(16)14
Avg Revenue beat(16)3.56%
PT rev (1m)-7.72%
PT rev (3m)-18.78%
EPS NQ rev (1m)-0.29%
EPS NQ rev (3m)-10.35%
EPS NY rev (1m)0.23%
EPS NY rev (3m)-7.18%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-6.35%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-7.05%
Valuation
Industry RankSector Rank
PE 34.58
Fwd PE 35.1
P/S 9.53
P/FCF 34.68
P/OCF 33.66
P/B 33.2
P/tB 41.92
EV/EBITDA 36.07
EPS(TTM)4.73
EY2.89%
EPS(NY)4.66
Fwd EY2.85%
FCF(TTM)4.72
FCFY2.88%
OCF(TTM)4.86
OCFY2.97%
SpS17.17
BVpS4.93
TBVpS3.9
PEG (NY)N/A
PEG (5Y)1.56
Profitability
Industry RankSector Rank
ROA 28.82%
ROE 73%
ROCE 73.23%
ROIC 60.22%
ROICexc 236.37%
ROICexgc 747.22%
OM 25.1%
PM (TTM) 20.95%
GM 54.82%
FCFM 27.47%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexcg growth 3YN/A
ROICexcg growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 137.68%
Cap/Sales 0.83%
Interest Coverage 250
Cash Conversion 110.12%
Profit Quality 131.12%
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 16.28
F-Score7
WACC10.9%
ROIC/WACC5.52
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)25.8%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%13.59%
EPS Next Y-1.49%
EPS Next 2Y4.87%
EPS Next 3Y8.81%
EPS Next 5Y17.55%
Revenue 1Y (TTM)12.24%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%7.36%
Revenue Next Year1.98%
Revenue Next 2Y4.97%
Revenue Next 3Y7.23%
Revenue Next 5Y8.65%
EBIT growth 1Y24.65%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year1.82%
EBIT Next 3Y9.41%
EBIT Next 5Y11.24%
FCF growth 1Y18.57%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y19.81%
OCF growth 3Y16.79%
OCF growth 5Y14.96%